Guidelines for Administering Intramuscular Injections in Patients on Oral Anticoagulant Therapy

Risk Assessment

Intramuscular injections in patients on oral anticoagulants are classified as a potential critical site bleed that could lead to compartment syndrome, paralysis, or limb loss in severe cases, as stated by the American College of Cardiology 1

The American College of Cardiology recommends assessing the patient's current anticoagulation status, including the type of anticoagulant (VKA or DOAC) 2
The patient's last dose timing should be assessed, according to the American College of Cardiology 3
Current laboratory values, such as INR for VKAs or specific assays for DOACs, should be evaluated, as suggested by the Journal of Thrombosis and Haemostasis 4
For patients on VKAs, the American College of Cardiology recommends checking INR before administration, with an optimal range of 2.0-3.0, and considering postponing the injection if INR is above 3.0 5
For patients on DOACs, the American College of Cardiology suggests considering the timing of the injection at the trough level and temporarily holding the DOAC dose if possible 6

The American College of Cardiology recommends using the smallest gauge needle appropriate for the medication 6
Firm pressure should be applied to the injection site for at least 5 minutes after administration, as stated by the American College of Cardiology 6
The ventrogluteal site is preferred over the dorsogluteal site when possible, according to the American College of Cardiology 6
Multiple injections at the same site should be avoided, as recommended by the American College of Cardiology 6

The injection site should be monitored for at least 10 minutes for signs of hematoma formation, as suggested by the American College of Cardiology 6
Patients should be instructed to report any unusual pain, swelling, or discoloration at the injection site, according to the American College of Cardiology 6
Healthcare providers should be vigilant for signs of compartment syndrome, such as pain, pallor, paresthesia, weakness, and diminished pulse, as stated by the American College of Cardiology 1

If bleeding occurs at the injection site, direct pressure should be applied to the area, as recommended by the American College of Cardiology 7
For minor bleeding or hematoma, local measures are usually sufficient, according to the American College of Cardiology 7
For major bleeding with signs of compartment syndrome, the anticoagulant should be stopped immediately, and reversal agents should be considered based on the specific anticoagulant, as suggested by the American College of Cardiology 7
Surgical consultation may be necessary for compartment syndrome, as stated by the American College of Cardiology 1